Coinbase Initiates Rally in Altcoins by Outlining Two Projects for Potential Listing on Its Exchange Platform
In a significant move, Coinbase, the leading US crypto exchange, has added Bio Protocol (BIO) and Euler (EUL) to its listing roadmap on July 29, 2025. This announcement signals that Coinbase is considering supporting trading for these tokens in the near future, although the exact trading launch is contingent upon meeting market-making and technical infrastructure conditions.
The announcement has set off a wave of excitement in the crypto market, with both tokens experiencing significant price rallies. Bio Protocol, a biotechnology-focused project, surged nearly 19%, reaching above $0.07 from around $0.061. Euler, a decentralized finance (DeFi) lending platform, initially jumped over 22% from about $13.50 to $16.50 but later stabilized near the $13.50-$14 range.
It is important to note that the addition to Coinbase's roadmap does not guarantee immediate trading. Coinbase clarifies that actual trading will commence only after securing sufficient liquidity and completing the necessary technical preparations. Users are cautioned against premature deposits.
Bio Protocol aims to "accelerate biotechnology by giving global communities of patients, scientists, and biotech professionals the ability to collectively fund, build, and own tokenized biotech projects and intellectual property." EUL, on the other hand, aspires to make "lending and borrowing simpler, more efficient, and more versatile, while giving users the freedom to explore new opportunities in DeFi."
As of late July 2025, neither token is live for trading on Coinbase, but their inclusion on the roadmap has generated significant market interest and price volatility ahead of the expected listing.
The Daily Hodl, a premier source for news, Bitcoin, Ethereum, Altcoins, Financeflux, Trading, NFTs, Blockchain, Futuremash, Regulators, Scams, Hacks & Breaches, and more, brings you this update. For the latest stories, visit our website or check out our categories, including Bitcoin, Ethereum, Trading, Altcoins, Futuremash, Financeflux, Blockchain, Regulators, Scams, HodlX, Press Releases.
Stay tuned for more updates on the future of finance, including macro, bitcoin, ethereum, crypto, and web 3. The Crypto Markets section is also available for submissions, including Guest Post, Press Release, Sponsored Post, and Advertise.
The Daily Hodl also covers Industry Announcements, such as Latest, Press Releases, Chainwire, Sponsored Posts, and the option to Submit Your Content.
At the time of writing, BIO is trading for $0.06963, up 9.1% in the last 24 hours. EUL, after a recent low of $12.63, is trading for $14.12.
Remember, this article is copyrighted © 2017-2025 by The Daily Hodl.
[1] Original Source 1 [2] Original Source 2 [3] Original Source 3 [4] Original Source 4 [5] Original Source 5
- Despite not yet being available for trading on Coinbase, the addition of Bio Protocol (BIO) and Euler (EUL) to its listing roadmap has sparked interest in the decentralized finance (DeFi) and altcoins sectors, contributing to significant price rallies for both tokens.
- As Coinbase continues to evaluate market-making and technical infrastructure conditions, trading for Bio Protocol and Euler could potentially expand the cryptocurrency finance landscape, aligning with their respective objectives of accelerating biotechnology or making DeFi lending and borrowing more accessible and versatile.
